Molecular Partners AG
MOLN
$3.77
-$0.20-5.04%
NASDAQ
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 11.09% | -9.44% | 1.11% | -25.63% | -153.42% |
Total Depreciation and Amortization | 5.07% | 2.82% | 6.48% | 10.05% | 7.77% |
Total Amortization of Deferred Charges | -37.51% | 6.18% | 6.18% | 6.18% | 6.18% |
Total Other Non-Cash Items | -158.51% | -22.07% | -96.45% | -71.29% | 60.89% |
Change in Net Operating Assets | 35.02% | -7.19% | 23.09% | 72.24% | -13.57% |
Cash from Operations | -2.47% | -12.64% | -5.45% | -4.23% | -150.31% |
Capital Expenditure | -24.39% | -9.61% | 19.62% | 23.31% | 47.92% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -7.99% | 11.48% | 330.11% | 2,242.71% | 147.19% |
Cash from Investing | -8.41% | 11.51% | 350.27% | 1,736.26% | 146.06% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -0.83% | -0.75% | -0.75% | -0.67% | -0.76% |
Issuance of Common Stock | 55,970.97% | 21.88% | 21.21% | 15.38% | -87.60% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 1,364.69% | -3.94% | 30.59% | 29.52% | 20.27% |
Foreign Exchange rate Adjustments | 117.61% | -6.60% | 27.91% | -589.85% | -2,198.16% |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 82.98% | -29.66% | 105.19% | 91.42% | -211.73% |